An API Innovation Center report highlighted four priorities to stabilize the U.S.-based supply of active pharmaceutical ingredients.
The report draws from roundtable discussions hosted at the nonprofit corporation in August, according to an Oct. 6 company news release. Leaders representing pharmaceutical manufacturing, hospital systems, retail pharmacies, government and the economic sector discussed what each needed to support a more reliable domestic supply chain. Currently, more than 250 medications are in shortage nationwide.
Here are the four priorities:
- Predictable demand and long-term contracts to de-risk private investment in U.S. manufacturing.
- A shift from lowest-cost purchasing to value-based models that reward reliability and quality.
- Greater transparency across the supply chain to enable smarter decisions and risk management.
- Broad stakeholder engagement to align incentives and ensure reliable access to critical medicines.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
